niraparib 200 MG Oral Tablet [Zejula]
- RxCUI
- 2640212
- RxNorm name
- niraparib 200 MG Oral Tablet [Zejula]
- Display name
- niraparib 200 MG Oral Tablet [Zejula]
- Full name
- niraparib 200 MG Oral Tablet [Zejula]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:17
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZEJULA | NIRAPARIB | GlaxoSmithKline LLC | b7f675e2-159c-490c-b6f4-3f16d9492b7d | 2026-03-27 | Warnings, Adverse reactions | 2640212 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| b7f675e2-159c-490c-b6f4-3f16d9492b7d | niraparib 200 MG Oral Tablet [Zejula] | SBD | 9 | These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017 | 20260327 |
| b7f675e2-159c-490c-b6f4-3f16d9492b7d | Zejula 200 MG Oral Tablet | SY | 9 | These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017 | 20260327 |
| b7f675e2-159c-490c-b6f4-3f16d9492b7d | Zejula 200 MG Oral Tablet | PSN | 9 | These highlights do not include all the information needed to use ZEJULA safely and effectively. See full prescribing information for ZEJULA. ZEJULA (niraparib) tablets, for oral use Initial U.S. Approval: 2017 | 20260327 |